manufactures a wide range of in vitro diagnostic (IVD) products, working with recognized suppliers of medical equipment to provide its clients with cost effective and accurate testing products.

Biozek is well known in the medical community as a solution provider company. Seeking to assist medical institutions in more effectively handling the current pandemic, Biozek has created several rapid tests that offer fast and accurate results: the COVID-19 Antibody Rapid Test, using serum or plasma samples, and two COVID-19 Antigen Rapid Tests that use nasal swabs, throat swabs, or saliva samples.

Through its creation of new technological platforms and business processes, Biozek has tapped into new techno-commercial areas of the point of care testing market. It teams with well-recognized suppliers of medical equipment to provide its customers with highly accurate and cost effective testing products. Biozek Medical has evolved into a global leader in the manufacture of in vitro diagnostic products. The Biozek rapid test for COVID-19 and its tests for other infectious diseases are regarded as world class products.

Biozek has leveraged the increased interest in point of care testing solutions, due to an increased specialization in medical facilities and the further decentralization of hospitals. Its commitment to manufacturing the highest quality products and pursuing effective and innovative solutions has helped Biozek to build strong partnerships and to grow a loyal customer base. It continues to improve the availability of high quality medical equipment and diagnostic tools with developing countries and to create a better workflow for point of care institutions.